Research Analysts Issue Forecasts for STOK FY2025 Earnings
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Cantor Fitzgerald increased their FY2025 earnings per share (EPS) estimates for Stoke Therapeutics in a research report issued to clients and investors on Thursday, March 20th. Cantor Fitzgerald analyst C. Duncan now expects that the company will earn $0.03 per share for the year, up from their […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Cantor Fitzgerald increased their FY2025 earnings per share (EPS) estimates for Stoke Therapeutics in a research report issued to clients and investors on Thursday, March 20th. Cantor Fitzgerald analyst C. Duncan now expects that the company will earn $0.03 per share for the year, up from their […]
